These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

404 related items for PubMed ID: 29969781

  • 1. MicroRNA-500a Promotes the Progression of Hepatocellular Carcinoma by Post-Transcriptionally Targeting BID.
    Bao L, Zhang M, Han S, Zhan Y, Guo W, Teng F, Liu F, Guo M, Zhang L, Ding G, Wang Q.
    Cell Physiol Biochem; 2018; 47(5):2046-2055. PubMed ID: 29969781
    [Abstract] [Full Text] [Related]

  • 2. miR-500a-3p promotes cancer stem cells properties via STAT3 pathway in human hepatocellular carcinoma.
    Jiang C, Long J, Liu B, Xu M, Wang W, Xie X, Wang X, Kuang M.
    J Exp Clin Cancer Res; 2017 Jul 27; 36(1):99. PubMed ID: 28750679
    [Abstract] [Full Text] [Related]

  • 3. A Preliminary Investigation of PVT1 on the Effect and Mechanisms of Hepatocellular Carcinoma: Evidence from Clinical Data, a Meta-Analysis of 840 Cases, and In Vivo Validation.
    Zhang Y, Wen DY, Zhang R, Huang JC, Lin P, Ren FH, Wang X, He Y, Yang H, Chen G, Luo DZ.
    Cell Physiol Biochem; 2018 Jul 27; 47(6):2216-2232. PubMed ID: 29975928
    [Abstract] [Full Text] [Related]

  • 4. MicroRNA-500a promotes migration and invasion in hepatocellular carcinoma by activating the Wnt/β-catenin signaling pathway.
    Guo Y, Chen L, Sun C, Yu C.
    Biomed Pharmacother; 2017 Jul 27; 91():13-20. PubMed ID: 28437633
    [Abstract] [Full Text] [Related]

  • 5. MicroRNA-450b-3p inhibits cell growth by targeting phosphoglycerate kinase 1 in hepatocellular carcinoma.
    Chen Z, Zhuang W, Wang Z, Xiao W, Don W, Li X, Chen X.
    J Cell Biochem; 2019 Nov 27; 120(11):18805-18815. PubMed ID: 31222833
    [Abstract] [Full Text] [Related]

  • 6. Upregulated in Hepatitis B virus-associated hepatocellular carcinoma cells, miR-331-3p promotes proliferation of hepatocellular carcinoma cells by targeting ING5.
    Cao Y, Chen J, Wang D, Peng H, Tan X, Xiong D, Huang A, Tang H.
    Oncotarget; 2015 Nov 10; 6(35):38093-106. PubMed ID: 26497554
    [Abstract] [Full Text] [Related]

  • 7. miR-3117 regulates hepatocellular carcinoma cell proliferation by targeting PHLPPL.
    Cui X, Li Q, He Y.
    Mol Cell Biochem; 2017 Jan 10; 424(1-2):195-201. PubMed ID: 27822662
    [Abstract] [Full Text] [Related]

  • 8. Long non-coding RNA NEAT1 promotes hepatocellular carcinoma cell proliferation through the regulation of miR-129-5p-VCP-IκB.
    Fang L, Sun J, Pan Z, Song Y, Zhong L, Zhang Y, Liu Y, Zheng X, Huang P.
    Am J Physiol Gastrointest Liver Physiol; 2017 Aug 01; 313(2):G150-G156. PubMed ID: 28526689
    [Abstract] [Full Text] [Related]

  • 9. MiR-221 Promotes Hepatocellular Carcinoma Cells Migration via Targeting PHF2.
    Fu Y, Liu M, Li F, Qian L, Zhang P, Lv F, Cheng W, Hou R.
    Biomed Res Int; 2019 Aug 01; 2019():4371405. PubMed ID: 31214616
    [Abstract] [Full Text] [Related]

  • 10. The long noncoding RNA AK002107 negatively modulates miR-140-5p and targets TGFBR1 to induce epithelial-mesenchymal transition in hepatocellular carcinoma.
    Tang YH, He GL, Huang SZ, Zhong KB, Liao H, Cai L, Gao Y, Peng ZW, Fu SJ.
    Mol Oncol; 2019 May 01; 13(5):1296-1310. PubMed ID: 30943320
    [Abstract] [Full Text] [Related]

  • 11. microRNA-18a Promotes Cell Migration and Invasion Through Inhibiting Dicer l Expression in Hepatocellular Carcinoma In Vitro.
    Zhang X, Yu B, Zhang F, Guo Z, Li L.
    Chin Med Sci J; 2017 Apr 10; 32(1):34-3. PubMed ID: 28399983
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. MicroRNA-548a-5p promotes proliferation and inhibits apoptosis in hepatocellular carcinoma cells by targeting Tg737.
    Zhao G, Wang T, Huang QK, Pu M, Sun W, Zhang ZC, Ling R, Tao KS.
    World J Gastroenterol; 2016 Jun 21; 22(23):5364-73. PubMed ID: 27340352
    [Abstract] [Full Text] [Related]

  • 14. Long noncoding RNA AWPPH promotes hepatocellular carcinoma progression through YBX1 and serves as a prognostic biomarker.
    Zhao X, Liu Y, Yu S.
    Biochim Biophys Acta Mol Basis Dis; 2017 Jul 21; 1863(7):1805-1816. PubMed ID: 28428004
    [Abstract] [Full Text] [Related]

  • 15. LncRNA CASC2 inhibited the viability and induced the apoptosis of hepatocellular carcinoma cells through regulating miR-24-3p.
    Fan JC, Zeng F, Le YG, Xin L.
    J Cell Biochem; 2018 Aug 21; 119(8):6391-6397. PubMed ID: 29091305
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Insight into the molecular mechanism of LINC00152/miR-215/CDK13 axis in hepatocellular carcinoma progression.
    Wang J, Zhang Y, Lu L, Lu Y, Tang Q, Pu J.
    J Cell Biochem; 2019 Nov 21; 120(11):18816-18825. PubMed ID: 31297882
    [Abstract] [Full Text] [Related]

  • 18. LncRNA SNHG14 aggravates invasion and migration as ceRNA via regulating miR-656-3p/SIRT5 pathway in hepatocellular carcinoma.
    Tang SJ, Yang JB.
    Mol Cell Biochem; 2020 Oct 21; 473(1-2):143-153. PubMed ID: 32607966
    [Abstract] [Full Text] [Related]

  • 19. CircRNA-104718 acts as competing endogenous RNA and promotes hepatocellular carcinoma progression through microRNA-218-5p/TXNDC5 signaling pathway.
    Yu J, Yang M, Zhou B, Luo J, Zhang Z, Zhang W, Yan Z.
    Clin Sci (Lond); 2019 Jul 15; 133(13):1487-1503. PubMed ID: 31278132
    [Abstract] [Full Text] [Related]

  • 20. MicroRNA-15a-5p suppresses cancer proliferation and division in human hepatocellular carcinoma by targeting BDNF.
    Long J, Jiang C, Liu B, Fang S, Kuang M.
    Tumour Biol; 2016 May 15; 37(5):5821-8. PubMed ID: 26581909
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.